Lupin yesterday entered into a partnership with Shenzhen Foncoo Pharmaceutical. This is Lupin’s first partnership arrangement in China and reinforces its commitment to bring high-quality generic and complex generic medicines to patients around the world, a company statement said.
The statement quoted Peng Yan, General Manager, Foncoo as saying, “…….We expect that the successful launch of our first product in China will come smoothly and soon. We will also continue exploring more opportunities to work with Lupin for providing more and more high-valued and complex medicines to the Chinese physicians and patients.”